However, clinical studies indicate that leptin is undesirable as a therapeutic regiment for obesity, which is at least partly attributed to the poorly understood complex secondary structure and key signaling mechanism of the leptin-responsive neural circuit. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.